BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsuchiya A, Takeuchi S, Watanabe T, Yoshida T, Nojiri S, Ogawa M, Terai S. Mesenchymal stem cell therapies for liver cirrhosis: MSCs as "conducting cells" for improvement of liver fibrosis and regeneration. Inflamm Regen. 2019;39:18. [PMID: 31516638 DOI: 10.1186/s41232-019-0107-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Yao Y, Xia Z, Cheng F, Jang Q, He J, Pan C, Zhang L, Ye Y, Wang Y, Chen S, Su D, Su X, Cheng L, Shi G, Dai L, Deng H. Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells. Stem Cell Res Ther 2021;12:294. [PMID: 34016164 DOI: 10.1186/s13287-021-02358-x] [Reference Citation Analysis]
2 Watanabe Y, Tsuchiya A, Terai S. The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future. Clin Mol Hepatol 2021;27:70-80. [PMID: 33317249 DOI: 10.3350/cmh.2020.0194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sanap A, Joshi K, Shah T, Tillu G, Bhonde R. Pre-conditioning of Mesenchymal Stem Cells with Piper longum L. augments osteogenic differentiation. J Ethnopharmacol 2021;273:113999. [PMID: 33705921 DOI: 10.1016/j.jep.2021.113999] [Reference Citation Analysis]
4 Iwasawa T, Nojiri S, Tsuchiya A, Takeuchi S, Watanabe T, Ogawa M, Motegi S, Sato T, Kumagai M, Nakaya T, Ohbuchi K, Nahata M, Fujitsuka N, Takamura M, Terai S. Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice. Regen Ther 2021;18:231-41. [PMID: 34409135 DOI: 10.1016/j.reth.2021.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dorairaj V, Sulaiman SA, Abu N, Abdul Murad NA. Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update. Biomolecules 2020;10:E1494. [PMID: 33143043 DOI: 10.3390/biom10111494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Nazhvani FD, Haghani I, Nazhvani SD, Namazi F, Ghaderi A. Regenerative effect of mesenteric fat stem cells on ccl4-induced liver cirrhosis, an experimental study. Ann Med Surg (Lond) 2020;60:135-9. [PMID: 33145022 DOI: 10.1016/j.amsu.2020.10.045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Muto H, Ito T, Tanaka T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Maeda K, Honda T, Ishikawa T, Kato A, Ohshiro T, Kano F, Yamamoto A, Sakai K, Hibi H, Ishigami M, Fujishiro M. Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis. Sci Rep 2021;11:18778. [PMID: 34548598 DOI: 10.1038/s41598-021-98254-8] [Reference Citation Analysis]
8 Zhang S, Hou Y, Yang J, Xie D, Jiang L, Hu H, Hu J, Luo C, Zhang Q. Application of mesenchymal stem cell exosomes and their drug-loading systems in acute liver failure. J Cell Mol Med 2020;24:7082-93. [PMID: 32492261 DOI: 10.1111/jcmm.15290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Takeuchi S, Tsuchiya A, Iwasawa T, Nojiri S, Watanabe T, Ogawa M, Yoshida T, Fujiki K, Koui Y, Kido T, Yoshioka Y, Fujita M, Kikuta J, Itoh T, Takamura M, Shirahige K, Ishii M, Ochiya T, Miyajima A, Terai S. Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis. NPJ Regen Med 2021;6:19. [PMID: 33785758 DOI: 10.1038/s41536-021-00132-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Tsai AC, Jeske R, Chen X, Yuan X, Li Y. Influence of Microenvironment on Mesenchymal Stem Cell Therapeutic Potency: From Planar Culture to Microcarriers. Front Bioeng Biotechnol 2020;8:640. [PMID: 32671039 DOI: 10.3389/fbioe.2020.00640] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 21.0] [Reference Citation Analysis]
11 Su DN, Wu SP, Xu SZ. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis. Stem Cell Res Ther 2020;11:395. [PMID: 32928296 DOI: 10.1186/s13287-020-01911-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tsuchiya A, Takeuchi S, Iwasawa T, Kumagai M, Sato T, Motegi S, Ishii Y, Koseki Y, Tomiyoshi K, Natsui K, Takeda N, Yoshida Y, Yamazaki F, Kojima Y, Watanabe Y, Kimura N, Tominaga K, Kamimura H, Takamura M, Terai S. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases. Inflamm Regen. 2020;40:14. [PMID: 32582401 DOI: 10.1186/s41232-020-00121-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 35.0] [Reference Citation Analysis]
13 Dwyer BJ, Macmillan MT, Brennan PN, Forbes SJ. Cell therapy for advanced liver diseases: Repair or rebuild. J Hepatol 2021;74:185-99. [PMID: 32976865 DOI: 10.1016/j.jhep.2020.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
14 Sungkar T, Putra A, Lindarto D, Sembiring RJ. Intravenous Umbilical Cord-derived Mesenchymal Stem Cells Transplantation Regulates Hyaluronic Acid and Interleukin-10 Secretion Producing Low-grade Liver Fibrosis in Experimental Rat. Med Arch 2020;74:177-82. [PMID: 32801431 DOI: 10.5455/medarh.2020.74.177-182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Cernigliaro V, Peluso R, Zedda B, Silengo L, Tolosano E, Pellicano R, Altruda F, Fagoonee S. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases. Cells 2020;9:E386. [PMID: 32046114 DOI: 10.3390/cells9020386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
16 Joo H, Oh MK, Kang JY, Park HS, Chae DH, Kim J, Lee JH, Yoo HM, Choi U, Kim DK, Lee H, Kim S, Yu KR. Extracellular Vesicles from Thapsigargin-Treated Mesenchymal Stem Cells Ameliorated Experimental Colitis via Enhanced Immunomodulatory Properties. Biomedicines 2021;9:209. [PMID: 33670708 DOI: 10.3390/biomedicines9020209] [Reference Citation Analysis]
17 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Reference Citation Analysis]
18 Bicer A, Ercin BS, Gürler T, Yiğittürk G, Uyanikgil Y, Cetin EO. Possibility of Taking an Offensive Stance in Extravasation Injury: Effects of Fat Injection in Vesicant (Doxorubicin) Induced Skin Necrosis Model in Rats. J Invest Surg 2021;:1-8. [PMID: 34402353 DOI: 10.1080/08941939.2021.1966142] [Reference Citation Analysis]
19 Zhao X, Zhu Y, Laslett AL, Chan HF. Hepatic Differentiation of Stem Cells in 2D and 3D Biomaterial Systems. Bioengineering (Basel) 2020;7:E47. [PMID: 32466173 DOI: 10.3390/bioengineering7020047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
20 Terai S, Tsuchiya A, Watanabe Y, Takeuchi S. Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment. Inflamm Regen 2021;41:27. [PMID: 34530931 DOI: 10.1186/s41232-021-00178-3] [Reference Citation Analysis]
21 Zhang B, Shang L, Zhang Y, Li T, Fang Y. The effect of bone marrow mesenchymal stem cells on highly metastatic MHCC97-H hepatocellular carcinoma cells following OPN and TGFβ1 gene silencing. Exp Ther Med 2020;20:3633-42. [PMID: 32855715 DOI: 10.3892/etm.2020.9106] [Reference Citation Analysis]
22 Xu HK, Chen LJ, Zhou SN, Li YF, Xiang C. Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases. World J Stem Cells 2020; 12(11): 1276-1294 [PMID: 33312398 DOI: 10.4252/wjsc.v12.i11.1276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
23 Quan M, Kuang S. Exosomal Secretion of Adipose Tissue during Various Physiological States. Pharm Res 2020;37:221. [PMID: 33063193 DOI: 10.1007/s11095-020-02941-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Dauletova M, Hafsan H, Mahhengam N, Zekiy AO, Ahmadi M, Siahmansouri H. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study. Clin Immunol 2021;226:108712. [PMID: 33684527 DOI: 10.1016/j.clim.2021.108712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Shiha G, Nabil A, Lotfy A, Soliman R, Hassan AA, Ali IS, Gad DF, Zahran F. Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis. Stem Cells Int 2020;2020:6574010. [PMID: 32089708 DOI: 10.1155/2020/6574010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
26 Watanabe T, Tsuchiya A, Takeuchi S, Nojiri S, Yoshida T, Ogawa M, Itoh M, Takamura M, Suganami T, Ogawa Y, Terai S. Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles. Regen Ther 2020;14:252-61. [PMID: 32455155 DOI: 10.1016/j.reth.2020.03.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]